Privigen
Payments companies reported to CMS as associated with Privigen. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Privigen, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Privigen
These are the largest totals companies reported as associated with Privigen. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Todd Levine | Phoenix, AZ | Neurology (Psychiatry & Neurology) | $11,935.39 |
| Jennifer Heimall | Philadelphia, PA | Pediatric Allergy/Immunology | $11,810.00 |
| Syed Mustafa | Rochester, NY | Allergy & Immunology | $11,768.40 |
| Said Beydoun | Los Angeles, CA | Clinical Neurophysiology | $10,907.69 |
| Richard Lewis | Los Angeles, CA | Neurology (Psychiatry & Neurology) | $9,812.84 |
| Nicholas Rider | Roanoke, VA | Allergy & Immunology | $8,841.78 |
| Jeffery Allen | Minneapolis, MN | Neurology (Psychiatry & Neurology) | $8,437.50 |
| Mark Ballow | Tampa, FL | Pediatric Allergy/Immunology | $7,224.90 |
| Antoine Azar | Baltimore, MD | Allergy & Immunology (Internal Medicine) | $5,333.00 |
| Mary Elizabeth Younger | Baltimore, MD | Pediatrics (Nurse Practitioner) | $5,164.99 |
Prescribed Privigen?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.